c-Fms
c-Fms-Inhibitoren richten sich gegen den Colony-Stimulating-Factor-1-Rezeptor (c-Fms), eine Tyrosinkinase, die an der Regulation von Makrophagen und anderen Immunzellen beteiligt ist. Die c-Fms-Signalgebung spielt eine Rolle bei der Proliferation, Differenzierung und dem Überleben dieser Zellen. Eine Fehlregulation von c-Fms wird mit Krankheiten wie Krebs, entzündlichen Erkrankungen und Osteoporose in Verbindung gebracht. Bei CymitQuimica bieten wir c-Fms-Inhibitoren an, um Ihre Forschung in den Bereichen Immunologie, Onkologie und entzündliche Erkrankungen zu unterstützen.
108 Produkte aus dem Bereich "c-Fms" gefunden
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
Mavrilimumab
CAS:<p>Mavrilimumab (CAM 3001), a monoclonal antibody, blocks GM-CSF signaling, potentially reducing inflammation in rheumatoid arthritis.</p>Reinheit:> 95% - > 95%Farbe und Form:LiquidMolekulargewicht:143.2 kDaCSF1R-IN-2
CAS:<p>CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).</p>Formel:C20H20FN7O2Reinheit:99.29%Farbe und Form:SolidMolekulargewicht:409.42Edicotinib
CAS:<p>Edicotinib (JNJ-527) is a blood-brain permeable, selective CSF-1R inhibitor, with lesser inhibitory effects on KIT and FLT3.Cost-effective and quality-assured.</p>Formel:C27H35N5O2Reinheit:98.58% - 99.72%Farbe und Form:SolidMolekulargewicht:461.6Axatilimab
CAS:<p>Axatilimab (SNDX-6352) is a human IgG4 antibody that targets CSF-1R and can be used to study immune system diseases and respiratory diseases.</p>Reinheit:97.9% (SDS-PAGE); 97% (SEC-HPLC) - 97.9% (SDS-PAGE); 97% (SEC-HPLC)Farbe und Form:LiquidCSF1R-IN-1
CAS:<p>CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.</p>Formel:C25H20F3N5O2Reinheit:97.02% - 98.56%Farbe und Form:SolidMolekulargewicht:479.45Lacnotuzumab
CAS:<p>Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, which can be used in research on retinal diseases.</p>Reinheit:>95%Farbe und Form:LiquidEmactuzumab
CAS:<p>Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has</p>Reinheit:SDS-PAGE:98.3%;SEC-HPLC:97.3%Farbe und Form:LiquidMolekulargewicht:144.4 kDaGENZ-882706(Raceme)
CAS:<p>GENZ-882706(Raceme) is the racemate of GENZ-882706.</p>Formel:C26H25N5O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:455.51Eflapegrastim
CAS:<p>Eflapegrastim: humanized IgG4 antibody and G-CSF that boosts neutrophils and shortens neutropenia.</p>Farbe und Form:LiquidcFMS Receptor Inhibitor IV
CAS:<p>cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.</p>Formel:C22H26N4O2Reinheit:99.70%Farbe und Form:SolidMolekulargewicht:378.47Antifibrotic agent 1
<p>Antifibrotic agent 1 is an orally active medication designed to treat idiopathic pulmonary fibrosis (IPF). It effectively mitigates IPF-related processes, including TGF-β-induced epithelial-mesenchymal transition (EMT) and fibroblast-to-myofibroblast transition (FMT), as well as profibrotic M2 polarization. Antifibrotic agent 1 selectively inhibits CSF-1R, PDGFR-α, and Src family kinases (SFKs), while sparing VEGFR, FGFR, and Abl to minimize off-target toxicity. In a bleomycin (BLM)-induced pulmonary fibrosis mouse model, it demonstrates strong antifibrotic activity.</p>Formel:C27H23ClN6O2Farbe und Form:SolidMolekulargewicht:498.1571Plonmarlimab
CAS:<p>Plonmarlimab(TJ003234) is an anti-GM-CSF monoclonal antibody with potential antiviral activity for the study of immune disorders and novel coronavirus infection</p>Reinheit:96.2% (SDS-PAGE); 95.4% (SEC-HPLC) - 96.2% (SDS-PAGE); 95.4% (SEC-HPLC)Farbe und Form:LiquidOtilimab
CAS:<p>Otilimab, a humanized monoclonal antibody, blocks GM-CSF to reduce inflammation and may treat severe COVID-19 pneumonia.</p>Reinheit:> 95%Farbe und Form:LiquidMolekulargewicht:142.22 kDaAMG-820
<p>AMG-820 is a human antibody targeting CSF-1R, inhibiting the binding of ligands CSF1 and IL34, and preventing subsequent ligand-induced receptor activation. For AMG-820's isotype control, refer to [Human IgG2 kappa, Isotype Control].</p>Farbe und Form:Odour LiquidPD-360324
<p>PD-360324 is a human monoclonal antibody (mAb) that targets CSF1/M-CSF. It can be utilized in research related to skin lupus, pulmonary sarcoidosis, and rheumatoid arthritis.</p>Farbe und Form:Odour LiquidPXB17
<p>PXB17 inhibits CSF1R activation (IC50= 1.7 nM) by blocking the PI3K/AKT/mTORC1 signaling pathway. It is effective orally, significantly suppresses the growth of colorectal cancer (CRC), enhances the efficacy of PD-1 monoclonal antibodies (PD-1mAb), and reduces the recurrence of CRC tumors.</p>Formel:C29H35N7O4Molekulargewicht:545.27505Sotuletinib hydrochloride
CAS:<p>Sotuletinib hydrochloride (BLZ945 HCl) is a selective, brain-penetrant CSF-1R (c-Fms) inhibitor (IC50=1 nM),for ALS and TNBC.</p>Formel:C20H23ClN4O3SReinheit:98.812%Farbe und Form:SolidMolekulargewicht:434.94PLX647 dihydrochloride
CAS:<p>PLX647 dihydrochloride: potent FMS/KIT inhibitor (IC50: 28/16 nM), highly selective, limited FLT3/KDR activity, oral use.</p>Formel:C21H19Cl2F3N4Farbe und Form:SolidMolekulargewicht:455.31Gimsilumab
CAS:<p>Gimsilumab (MORAb-022) is an anti-c-Fms humanized monoclonal antibody for the study of inflammation and hypoxemia caused by COVID-19.</p>Reinheit:99.49% (SEC-HPLC) - 99.49% (SEC-HPLC)Farbe und Form:LiquidMolekulargewicht:145.8 kDaM4205
CAS:<p>M4205 is an inhibitor of c-Kit exhibiting high activity on c-Kit mutations in exons 11, 13, 17.</p>Formel:C29H32N8OReinheit:99.07%Farbe und Form:SolidMolekulargewicht:508.62
